These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2063165)

  • 21. [Therapy of non-ulcer dyspepsia].
    Cortese I; Maselli MA
    Clin Ter; 1990 Apr; 133(2):103-7. PubMed ID: 2140745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastroesophageal reflux: clinical presentation in two pairs of twins.
    Iacono G; Carroccio A; Montalto G; Cavataio F; Balsamo V
    J Pediatr Gastroenterol Nutr; 1992 May; 14(4):460-2. PubMed ID: 1517951
    [No Abstract]   [Full Text] [Related]  

  • 23. Prokinetic therapy for gastroesophageal reflux disease.
    Robinson M
    Am Fam Physician; 1995 Sep; 52(3):957-62, 965-6. PubMed ID: 7653432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group.
    Castell DO; Sigmund C; Patterson D; Lambert R; Hasner D; Clyde C; Zeldis JB
    Am J Gastroenterol; 1998 Apr; 93(4):547-52. PubMed ID: 9576446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison between cisapride and Gaviscon with Carobel in the treatment of gastro-oesophageal reflux in infancy.
    Greally P; Hampton FJ; MacFadyen UM; Simpson H
    Ir Med J; 1992; 85(4 Suppl):14. PubMed ID: 1490841
    [No Abstract]   [Full Text] [Related]  

  • 26. Chronic functional dyspepsia: short- and medium-term outcome of a therapeutic trial with cisapride.
    Rösch W
    Clin Ther; 1994; 16(3):437-45. PubMed ID: 7923310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug therapy of gastrointestinal motility disorders].
    Jia B
    Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):151-2. PubMed ID: 7648932
    [No Abstract]   [Full Text] [Related]  

  • 28. [A retrospective study on the efficacy of the treatment of functional dyspepsia. An evaluation of 166 cases].
    Canepa G; Di Somma C; Arnulfo G; Frascio M; Berti Riboli E
    Minerva Med; 1991 Jun; 82(6):371-3. PubMed ID: 2067709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A new granular effervescent 10-mg formulation of cisapride in the treatment of gastroesophageal reflux].
    Grossi L; Di Felice F; Marzio L
    Clin Ter; 1993 Feb; 142(2):127-33. PubMed ID: 8472526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modern management of dyspepsia.
    Talley NJ
    Aust Fam Physician; 1996 Jan; 25(1):47-52. PubMed ID: 8607775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prokinetics in reflux disease. Action mechanisms and clinical effects].
    Hatlebakk JG; Berstad A
    Tidsskr Nor Laegeforen; 1994 Feb; 114(6):689-92. PubMed ID: 8191452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisapride marketed for use in gastroesophageal reflux disease.
    Clin Pharm; 1993 Dec; 12(12):876, 879. PubMed ID: 8137603
    [No Abstract]   [Full Text] [Related]  

  • 33. Gastric emptying in patients with non ulcer dyspepsia (dysmotility type).
    Mittal BR; Dhiman RK; Maini A; Sewatkar AB; Das BK
    Trop Gastroenterol; 1997; 18(2):67-9. PubMed ID: 9323919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents.
    McCallum RW
    Gastroenterol Clin North Am; 1990 Sep; 19(3):551-64. PubMed ID: 1977702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current concepts concerning functional dyspepsia syndrome].
    Sheptulin AA
    Klin Med (Mosk); 1995; 73(4):27-31. PubMed ID: 7474812
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of cisapride and cimetidine on 24-hour intraesophageal pH monitoring in patients with gastroesophageal reflux disease.
    Chojnacki J; Tkaczewski W; Wichan P; Grzegorczyk K; Klupińska G
    Mater Med Pol; 1992; 24(3):196-8. PubMed ID: 1307654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacologic and clinical differentiation of prokinetic drugs].
    May B; Greving I
    Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of gastro-oesophageal reflux and gastric stasis: new perspectives with cisapride. Proceedings of a symposium of the 13th International Congress of Gastroenterology. Rome, 6 September 1988.
    Scand J Gastroenterol Suppl; 1989; 165():1-65. PubMed ID: 2602909
    [No Abstract]   [Full Text] [Related]  

  • 39. Cisapride.
    Molinari F; Farrington E
    Pediatr Nurs; 1994; 20(2):202-3. PubMed ID: 8159508
    [No Abstract]   [Full Text] [Related]  

  • 40. Cisapride: influence on oesophageal and gastric emptying and gastro-oesophageal reflux in patients with reflux oesophagitis.
    Collins BJ; Spence RA; Ferguson R; Laird J; Love AH
    Hepatogastroenterology; 1987 Jun; 34(3):113-6. PubMed ID: 3301606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.